Management of Arthritis Associated with Inflammatory Bowel Disease (IBD): A Systematic Review of Conventional and Targeted Therapies

Authors

  • Iqbal Habibie Departemen Studi Penyakit Dalam, Fakultas Kedokteran, Universitas Andalas, Indonesia
  • Najirman Departemen Studi Penyakit Dalam, Divisi Reumatologi, Fakultas Kedokteran, Universitas Andalas, Indonesia
  • Eka Kurniawan Departemen Studi Penyakit Dalam, Divisi Reumatologi, Fakultas Kedokteran, Universitas Andalas, Indonesia

DOI:

https://doi.org/10.51601/ijhp.v6i3.681

Abstract

Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic inflammatory disorder of the gastrointestinal tract associated with significant extraintestinal manifestations. Arthritis is the most frequent extraintestinal manifestation, with an overall prevalence of 17–39%, and is classified as a subtype of spondyloarthritis involving axial and/or peripheral joints. Peripheral arthritis is generally non-erosive, with the oligoarticular variant correlating with intestinal disease activity, whereas axial arthritis—including sacroiliitis and ankylosing spondylitis—tends to progress independently of bowel disease activity. This narrative review aims to provide a comprehensive overview of IBD-associated arthritis, covering its definition, epidemiology, pathogenesis, clinical manifestations, diagnosis, and management. Pathogenesis involves three interconnected mechanisms: extension of intestinal immune responses, gut microbiota dysregulation through Th17 pathway activation, and genetic predisposition mediated by HLA-B27 and NOD2/CARD15. Diagnosis relies on ASAS clinical criteria, with MRI as the preferred modality for early detection of axial involvement. Management requires an integrated approach; TNF-α inhibitors serve as first-line therapy in active disease, while JAK inhibitors, ustekinumab, and vedolizumab represent promising novel therapeutic options. Multidisciplinary collaboration between gastroenterologists and rheumatologists is essential to optimize long-term clinical outcomes.

Downloads

Download data is not yet available.

References

[1]. Arvikar, S. L., & Fisher, M. C. (2011). Inflammatory bowel disease associated arthropathy. Current Reviews in Musculoskeletal Medicine, 4(3), 123–131. https://doi.org/10.1007/s12178-011-9085-8

[2]. Ashrafi, M., Kuhn, K. A., & Weisman, M. H. (2021). The arthritis connection to inflammatory bowel disease (IBD): why has it taken so long to understand it? RMD Open, 7(1), e001558. https://doi.org/10.1136/rmdopen-2020-001558

[3]. Ashton, J. J., Satsangi, J., & Uhlig, H. H. (2024). Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk. Gastroenterology, 167(2), 205–208. https://doi.org/10.1053/j.gastro.2024.03.040

[4]. Balbir-Gurman, A., Schapira, D., & Nahir, M. (2001). Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis. Seminars in Arthritis and Rheumatism, 30(4), 242–248. https://doi.org/10.1053/sarh.2001.19960

[5]. Braun, J., & Baraliakos, X. (2011). Imaging of axial spondyloarthritis including ankylosing spondylitis. Annals of the Rheumatic Diseases, 70, i97–i103. https://doi.org/10.1136/ard.2010.140541

[6]. Calin, A. (1977). Clinical History as a Screening Test for Ankylosing Spondylitis. JAMA: The Journal of the American Medical Association, 237(24), 2613. https://doi.org/10.1001/jama.1977.03270510035017

[7]. Danoy, P., Pryce, K., Hadler, J., Bradbury, L. A., Farrar, C., Pointon, J., Ward, M., Weisman, M., Reveille, J. D., Wordsworth, B. P., Stone, M. A., Maksymowych, W. P., Rahman, P., Gladman, D., Inman, R. D., & Brown, M. A. (2010). Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn’s Disease. PLoS Genetics, 6(12), e1001195. https://doi.org/10.1371/journal.pgen.1001195

[8]. Dougados, M., Linden, S. Van Der, Juhlin, R., Huitfeldt, B., Amor, B., Calin, A., Cats, A., Dijkmans, B., Olivieri, I., Pasero, G., Veys, E., & Zeidler, H. (1991). The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy. Arthritis & Rheumatism, 34(10), 1218–1227. https://doi.org/10.1002/art.1780341003

[9]. Faggiani, I., Fanizza, J., D’Amico, F., Allocca, M., Zilli, A., Parigi, T. L., Barchi, A., Danese, S., & Furfaro, F. (2024). Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment. Biomedicines, 12(8), 1839. https://doi.org/10.3390/biomedicines12081839

[10]. Falloon, K., Dossaji, Z., Mude, P., Abushamma, S., Ananthakrishnan, A., Barnes, E. L., Bhalla, J., Bhattacharya, A., Cheemalavagu, S., Colombel, J.-F., Cross, R. K., Ermann, J., Ha, C., Herfarth, H., Horst, S., Hou, J., Husni, M. E., Kline, T. M., Kuhn, K. A., … Rieder, F. (2025). Diagnosis of Inflammatory Bowel Disease–Associated Peripheral Arthritis: A Systematic Review. Inflammatory Bowel Diseases, 31(3), 812–842. https://doi.org/10.1093/ibd/izae114

[11]. Macaluso, F. S., Caprioli, F., Benedan, L., Bezzio, C., Caporali, R., Cauli, A., Chimenti, M. S., Ciccia, F., D’Angelo, S., Fantini, M. C., Festa, S., Iannone, F., Lubrano, E., Mariani, P., Papi, C., Provenzano, G., Pugliese, D., Rispo, A., Saibeni, S., … Gerli, R. (2024). The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus. Autoimmunity Reviews, 23(5), 103533. https://doi.org/10.1016/j.autrev.2024.103533

[12]. Meisinger, C., & Freuer, D. (2022). Rheumatoid arthritis and inflammatory bowel disease: a bidirectional two-sample Mendelian randomization study. Seminars in Arthritis and Rheumatism, 55, 151992.

[13]. Orchard, T. R. (2012). Management of arthritis in patients with inflammatory bowel disease. Gastroenterology & Hepatology, 8(5), 327–329.

[14]. Peluso, R., Di Minno, M. N. D., Iervolino, S., Manguso, F., Tramontano, G., Ambrosino, P., Esposito, C., Scalera, A., Castiglione, F., & Scarpa, R. (2013). Enteropathic Spondyloarthritis: From Diagnosis to Treatment. Clinical and Developmental Immunology, 2013, 1–12. https://doi.org/10.1155/2013/631408

[15]. Perhimpunan Reumatologi Indonesia. (2021). Diagnosis dan Pengelolaan Spondiloartritis: Rekomendasi PB-IRA 2021.

[16]. Perkumpulan Gastroenterologi Indonesia. (2022). Konsensus nasional penatalaksanaan inflammatory bowel disease (IBD) di Indonesia (Revisi 2022).

[17]. Reveille, J. D. (2011). The genetic basis of spondyloarthritis. Annals of the Rheumatic Diseases, 70, i44–i50. https://doi.org/10.1136/ard.2010.140574

[18]. Rudwaleit, M., Jurik, A. G., Hermann, K.-G. A., Landewé, R., van der Heijde, D., Baraliakos, X., Marzo-Ortega, H., Østergaard, M., Braun, J., & Sieper, J. (2009). Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Annals of the Rheumatic Diseases, 68(10), 1520 LP – 1527. https://doi.org/10.1136/ard.2009.110767

[19]. Schwartzman, M., Ermann, J., Kuhn, K. A., Schwartzman, S., & Weisman, M. H. (2022). Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs. RMD Open, 8(1), e001777. https://doi.org/10.1136/rmdopen-2021-001777

[20]. Sęk, M., Duchnevič, O., Galasińska, I., Hajduk-Maślak, K., Szypuła, A., Michalik, B., & Skóra, A. (2024). Latest Treatment Perspectives for IBD-related Arthritis - a review. Journal of Education, Health and Sport, 61, 55–72. https://doi.org/10.12775/JEHS.2024.61.004

[21]. Sieper, J., van der Heijde, D., Landewé, R., Brandt, J., Burgos-Vagas, R., Collantes-Estevez, E., Dijkmans, B., Dougados, M., Khan, M. A., Leirisalo-Repo, M., van der Linden, S., Maksymowych, W. P., Mielants, H., Olivieri, I., & Rudwaleit, M. (2009). New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Annals of the Rheumatic Diseases, 68(6), 784–788. https://doi.org/10.1136/ard.2008.101501

[22]. Turner, M. J., Sowders, D. P., DeLay, M. L., Mohapatra, R., Bai, S., Smith, J. A., Brandewie, J. R., Taurog, J. D., & Colbert, R. A. (2005). HLA-B27 Misfolding in Transgenic Rats Is Associated with Activation of the Unfolded Protein Response. The Journal of Immunology, 175(4), 2438–2448. https://doi.org/10.4049/jimmunol.175.4.2438.

Downloads

Published

2026-08-30

How to Cite

Habibie, I., Najirman, & Kurniawan, E. (2026). Management of Arthritis Associated with Inflammatory Bowel Disease (IBD): A Systematic Review of Conventional and Targeted Therapies . International Journal of Health and Pharmaceutical (IJHP), 6(3), 794–807. https://doi.org/10.51601/ijhp.v6i3.681

Issue

Section

Articles